Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Ultrasound-Guided PENG Block for Chronic Shoulder Pain

Official title: Evaluation of the Analgesic Efficacy and Functional Outcomes of Ultrasound-Guided PENG Block in Chronic Shoulder Pain

Run by Ankara City Hospital Bilkent · NCT07607691 · Data updated 2026-11-12

This study tests whether an ultrasound-guided Pericapsular Nerve Group (PENG) block can improve pain and function in adults with chronic shoulder pain who haven’t responded to standard treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara, çankaya)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJuly 1, 2027
Study endsJuly 15, 2027
Registry record updatedNovember 9, 2026
Trial IDNCT07607691 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with chronic shoulder pain (>3 months) who have not responded to conservative treatment and are eligible for ultrasound-guided shoulder PENG block.

Probably not a fit

Patients with active infections, recent shoulder surgery within 6 months, coagulation disorders, or allergies to lidocaine or dexamethasone may not benefit or may be excluded for safety reasons.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational study at a single center evaluating ultrasound-guided PENG block in adults with chronic shoulder pain. Thirty-five to forty-five participants (up to 45) who have not improved with conservative care will receive a PENG block as part of routine care, using lidocaine and dexamethasone. Outcomes focus on pain and functional measures over follow-up visits, with careful screening to exclude those with bleeding disorders, active infection, recent shoulder surgery, or allergies to study medications. The study adheres to ethical standards and requires informed consent. It aims to characterize safety, feasibility, and short-term effectiveness in real-world clinical practice.

Why it matters

Potential benefit: If successful, patients could experience reduced pain and improved shoulder function after the block.

How similar studies have gone: Prior work on PENG blocks for shoulder conditions has shown promise for analgesia, though data in chronic shoulder pain are still developing and this study contributes real-world observations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Patients presenting with chronic shoulder pain lasting longer than 3 months.
* Initial pain intensity score greater than 4 on the Numerical Rating Scale (NRS \> 4).
* Patients who have not responded to conservative or medical treatments.
* Voluntary acceptance of the ultrasound-guided shoulder PENG block treatment and compliance with the scheduled follow-up protocol.

Exclusion Criteria:

* Patients currently using anticoagulants or diagnosed with coagulation disorders (bleeding diathesis).
* Patients with psychomotor or cognitive disorders that prevent cooperative evaluation.
* Presence of active bacterial infection, open wounds, or infectious discharge at the planned needle injection site.
* History of shoulder surgery at the intervention site within the last 6 months.
* Known allergy or hypersensitivity to local anesthetics (lidocaine) or corticosteroids (dexamethasone).
* Pregnant or breastfeeding patients.
* Patients who reject the procedure or fail to comply with the scheduled follow-up visits.

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, çankaya, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: ali çoştu, md — Ankara City Hospital Bilkent
  • Study coordinator: ali çoştu, md
  • Email: alicostu@gmail.com
  • Phone: +905427669038

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.